US Patent Number

10,668,030

Publication Date

6-2-2020

Abstract

The present invention relates to methods of treatment of a disease or pathology of the central nervous system, an eating disorder, or substance use disorder, drug dependence/abuse and withdrawal therefrom comprising administering at least one N-phenylalkyl amphetamine derivative and pharmaceutical compositions comprising at least one N-phenylalkyl amphetamine derivative to an individual in need thereof.

Assignees

University of Kentucky Research Foundation, Lexington, KY (US)

Application Number

15/493,836

Filing Date

4-21-2017

Share

COinS